| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.094 | 0.5 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |